Guangdong Provincial People's Hospital
3 clinical trials · 3 recruiting · OTHER
Trials by Guangdong Provincial People's Hospital
RECRUITINGNCT05841186
Correlation of Timing of Pegfilgrastim Administration and PIBP.
According to the National Comprehensive Cancer Network (NCCN) guidelines, patients receiving high-risk or moderate-risk febrile neutropenia (FN) chemotherapy with at least one...
Sponsor: Guangdong Provincial People's HospitalEnrolling: 1561 location
PegfilgrastimBone PainChemotherapy+3
RECRUITINGPhase 2NCT06300424
Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC
Phase II, single-arm, open-label study that assess clinical feasibility and safety of neoadjuvant almonertinib followed by 3 cycles neoadjuvant adebrelimab plus chemotherapy in...
Sponsor: Guangdong Provincial People's HospitalEnrolling: 321 location
Non Small Cell Lung CancerEGFR Gene Mutation
RECRUITINGPhase 1NCT06676631
NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
This is an investigator-initiated, open-label, single-arm study to determine safety and preliminary efficacy of NK010 or NK042 in combination with rituximab (RTX) for the...
Sponsor: Guangdong Provincial People's HospitalEnrolling: 181 location
Refractory Systemic Lupus ErythematosusRefractory Lupus Nephritis